Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(152)
•••
Comment by Hankerchiefon May 29, 2020 2:22pm
141 Views
Post# 31089038

RE:RE:RE:RE:Is MDNA holding TLT back?

RE:RE:RE:RE:Is MDNA holding TLT back?
LaserStock29 wrote:
Quattro74 wrote:
I think when TLT is a known disruptor of Lung or Breast cancer it is a $25-$45 US stock. GBM would be nice indication  but not a huge $$$$ maker IMO, just nor enuf % of persons effected.



Who cares right now..... how does that help us

1. Onboard the US hospitals and Doctors
2. Get the Fast Track approval
3. Hit $2 bux from the 2019 AGM



after $2... i hope TLT does a PP , establishes a floor... uplists to Nasd Cap..... and stays independent... and launch GBM... absolutely im onboard with that in 2020.

That would be a great year.

Shoot at this point.. just getting a phase 1 valuation of .80c or 160m cap would be an accomplishment




Would love to see TLTFF get back up to around .32 just to be even in my IRA and .28 to be even in my Individual Brokerage acct.....then if meant to be above that.   I'm getting a little frustrated.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities